AmerisourceBergen Corporation (ABC) Gets a Hold Rating from Barclays


Barclays analyst Steven Valiquette maintained a Hold rating on AmerisourceBergen Corporation (ABC) on January 18 and set a price target of $89. The company’s shares closed on Friday at $79.86.

According to TipRanks.com, Valiquette is a 4-star analyst with an average return of 5.2% and a 52.1% success rate. Valiquette covers the Services sector, focusing on stocks such as Patterson Companies Inc, WellCare Health Plans, and Molina Healthcare.

AmerisourceBergen Corporation has an analyst consensus of Moderate Buy, with a price target consensus of $88.71.

See today’s analyst top recommended stocks >>

AmerisourceBergen Corporation’s market cap is currently $17.03B and has a P/E ratio of 10.63. The company has a Price to Book ratio of 5.81.

Based on the recent corporate insider activity of 82 insiders, corporate insider sentiment is negative on the stock. Most recently, in November 2018, Lazarus Krikorian, the SVP of ABC sold 20,276 shares for a total of $1,832,342.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts